Hepatitis C Virus
New data from Sweden, Canada and Germany lluminates research in hepatitis C virus
Published in Hepatitis Weekly, July 24th, 2006
Study 1: According to recently published research from Sweden, hepatitis C virus (HCV) in hemodialysis responds to pegylated interferon and ribavirin.
"Standard therapy for chronic HCV is pegylated interferon in combination with ribavirin. There is limited experience with either drug in dialysis [end stage renal disease (ESRD)]," wrote A. Bruchfeld and colleagues, Karolinska Institute.
They explained, "Six haemodialysis patients, four with HCV genotype 1, one with genotype 4 and one genotype 2 were treated with pegylated interferon-alfa-2b (n=4) and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2006-07-24)
More Articles from Hepatitis Weekly
- Apoptosis
Cytokine-induced hepatic apoptosis is dependent on fgl2/fibroleukin - Hepatitis A Virus
Hepatitis A virus entry into target cells is facilitated by a membrane protein - Hepatitis B Virus
Impaired T cell function restored by cytokines in chronic hepatitis B infection - Hepatitis C Virus Vaccine
Dendritic cells expressing HCV antigen prime Ag-specific T cells from uninfected persons - Hepatitis D Virus
Defective hepatitis delta virus RNA genomes restored in vivo - Apoptosis
Apoptosis may be induced via a hepatitis C virus mitochondrial-related caspase pathway - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
